ABCG2-Mediated SN-38 Efflux Drives Resistance to Sacituzumab Govitecan in Urothelial Carcinoma. Academic Article uri icon

Overview

publication date

  • January 13, 2026

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.canlet.2026.218254

PubMed ID

  • 41539407